Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 605-608

  Huang, Hui Chun ^a,b   Wu, Jaw Ching ^a,b   Huang, Yi Shin ^a,b   Huo, Teh Ia ^a,b   Lo, Jing Chuan ^a,b   Li, Chun Ping ^a,b   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Autoimmune hepatitis; Human leukocyte antigen

Indexed keywords

AMINOTRANSFERASE; CD45 ANTIGEN; HLA A1 ANTIGEN; HLA A11 ANTIGEN; HLA B35 ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; PREDNISOLONE;

ADULT; AGED; ALLELE; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETICS; HEALTH SURVEY; HLA SYSTEM; HLA TYPING; HUMAN; JAPANESE; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; TIME SERIES ANALYSIS; TREATMENT RESPONSE;

FEMALE; HEPATITIS, AUTOIMMUNE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; TAIWAN;

EID: 44349124533     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Johnson PJ, Mcfarlane IG, EddLeston ALWF: The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 1991; 11:187-196.
2. Boberg KM, AadLand E, Jahnsen J, Raknerud N, Stiris M, Bell H: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33:99-103.
3. Opelz G, Vogten A J M, Summerskill WHJ, Schalm SW, Terasaki PI: HLA determinants in chronic active liver disease: possible relation of Dw3 to prognosis. Tissue Antigens 1977; 9:36-40.
4. Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, et al: Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 1998; 161:3527-3535.
5. Donaldson PT, Doherty DG, Hayllar KM, Mcfarlane IG, Johnson P, Williams R: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13:701-706.
6. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 1997; 25:317-323.
7. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, et al: HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103:1041-1047.
8. Qiu DK, Ma X: Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. J Gastroenterol Hepatol 2003; 18:63-67.
9. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL: Base line seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986; 18:301-307.
10. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.
11. Shaw CK, Chang TK, Chen SN, Wu S: HLA polymorphism and probability of finding HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 1997; 50:610-619.
12. Mcfarlane IG: Pathogenesis of autoimmune hepatitis. Biomed Pharmacother 1999; 53:255-263.
13. Lin M, Chu CC, Chang SL, Lee HL, Loo JH, Akaza T, et al: The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study. Tissue Antigens 2001; 57:192-199.
14. Yoon SK, Han JY, Pyo CW, Yang JM, Jang JW, Kim CW, et al: Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver Intern 2005; 25:1122-1127.
15. Mota AH, Fainboim H, Terg R, Fainboim L: Association of chronic active hepatitis and HLA B35 in patients with hepatitis B virus. Tissue Antigens 1987; 30:238-240.
16. van Hattum J, Schreuder GM, Schalm SW: HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987; 7:11-14.
17. Omagari K, Kinoshita H, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, et al: Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 1999; 34:221-226.
18. Sherlock S, Dooley J: Chronic hepatitis: general features and autoimmune chronic disease. In: Sherlock S, Dooley J (Eds.). Diseases of the Lliver and Biliary System. Oxford: Blackwell, 2002; pp.321-333.
19. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al, and the Japanese National Study Group of Autoimmune Hepatitis: Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 1997; 26:1207-1212.
20. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993; 105:1502-1507.
21. Lee YM, Teo EK, Ng TM, Khor C, Fock KM: Autoimmune hepatitis in Singapore: a rare syndrome affecting middLe-aged women. J Gastroenterol Hepatol 2001; 16:384-389.
22. Kosar Y, Kacar S, Sasmaz N, Oguz P, Turhan N, Parlak E, et al: Type 1 autoimmune hepatitis in Turkish patients: absence of association with HLA B8. J Clin Gastroenterol 2002; 35:185-190.
23. Czaja AJ: Autoimmune chronic active hepatitis. In: Czaja AJ, Dickson ER (Eds.). Chronic Active Hepatitis: The Mayo Clinic Experience. New York: Dekker, 1986; pp.105-126.